This post was originally published on this site
The company has a history of long-term share price weakness. The stock has lost 46.8% over the past three years and 45.5% over the past five years.
MBII announced in February 2021 that it had filed a ‘universal shelf’ registration statement with the SEC, under which it may sell various securities from time to time over three years. While this could help the company raise capital, it could also lead to share dilution. Furthermore, analysts recently made a significant negative revision to their near-term EPS estimates for MBII. So, its near-term prospects look bleak.
